117 related articles for article (PubMed ID: 20331999)
21. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
[TBL] [Abstract][Full Text] [Related]
22. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P
Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012
[TBL] [Abstract][Full Text] [Related]
23. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
[TBL] [Abstract][Full Text] [Related]
25. Rimonabant reduces the essential value of food in the genetically obese Zucker rat: an exponential demand analysis.
Rasmussen EB; Reilly W; Buckley J; Boomhower SR
Physiol Behav; 2012 Feb; 105(3):734-41. PubMed ID: 22019829
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
27. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
Pério A; Barnouin MC; Poncelet M; Soubrié P
Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
[TBL] [Abstract][Full Text] [Related]
28. Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.
Marusich JA; Wiley JL
Pharmacol Biochem Behav; 2012 Jun; 101(4):575-80. PubMed ID: 22425597
[TBL] [Abstract][Full Text] [Related]
29. Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.
Sink KS; Segovia KN; Nunes EJ; Collins LE; Vemuri VK; Thakur G; Makriyannis A; Salamone JD
Psychopharmacology (Berl); 2009 Oct; 206(2):223-32. PubMed ID: 19588124
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat.
Chambers AP; Sharkey KA; Koopmans HS
Physiol Behav; 2004 Oct; 82(5):863-9. PubMed ID: 15451651
[TBL] [Abstract][Full Text] [Related]
31. Rimonabant's reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats.
Buckley JL; Rasmussen EB
Psychopharmacology (Berl); 2014 May; 231(10):2159-70. PubMed ID: 24398820
[TBL] [Abstract][Full Text] [Related]
32. CB1 antagonism produces behaviors more consistent with satiety than reduced reward value in food-maintained responding in rats.
Thompson EE; Jagielo-Miller JE; Vemuri VK; Makriyannis A; McLaughlin PJ
J Psychopharmacol; 2016 May; 30(5):482-91. PubMed ID: 27005309
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid effects on behaviors maintained by ethanol or food: a within-subjects comparison.
Ginsburg BC; Lamb RJ
Behav Pharmacol; 2006 May; 17(3):249-57. PubMed ID: 16572003
[TBL] [Abstract][Full Text] [Related]
34. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
35. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940).
Ward SJ; Dykstra LA
Behav Pharmacol; 2005 Sep; 16(5-6):381-8. PubMed ID: 16148442
[TBL] [Abstract][Full Text] [Related]
36. Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.
De Vry J; Schreiber R; Eckel G; Jentzsch KR
Eur J Pharmacol; 2004 Jan; 483(1):55-63. PubMed ID: 14709326
[TBL] [Abstract][Full Text] [Related]
37. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.
Thornton-Jones ZD; Vickers SP; Clifton PG
Psychopharmacology (Berl); 2005 May; 179(2):452-60. PubMed ID: 15821957
[TBL] [Abstract][Full Text] [Related]
38. Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice.
Ward SJ; Walker EA
Behav Pharmacol; 2009 Oct; 20(7):605-13. PubMed ID: 19745722
[TBL] [Abstract][Full Text] [Related]
39. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats.
Shoaib M
Neuropharmacology; 2008 Feb; 54(2):438-44. PubMed ID: 18054052
[TBL] [Abstract][Full Text] [Related]
40. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.
Hernandez G; Cheer JF
J Neurosci; 2012 Aug; 32(33):11467-77. PubMed ID: 22895729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
